Meloxicam

Overview

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain and inflammation in rheumatic diseases and osteoarthritis. It works by inhibiting the synthesis of prostaglandins, which play a key role in inflammation.

API suppliers (41)

Suppliers of Meloxicam backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Unichem Laboratories Ltd.India1 active DMF
• ARCH PHARMALABS LTD1 active DMF
• BIDACHEM SPA1 active DMF
• Cipla USA, Inc.USA1 active DMF
• UNIMARK REMEDIES LTD1 active DMF
• SWATI SPENTOSE PRIVATE LTD1 active DMF
• AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPA1 active DMF
• Cipla USA, Inc.USA1 active DMF
• ARCH PHARMALABS LTD1 active DMF
• Unichem Laboratories Ltd.India1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• Unichem Laboratories Ltd.India1 active DMF
• BIDACHEM SPA1 active DMF
• QUIMICA SINTETICA SASpain1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• SWATI SPENTOSE PRIVATE LTD1 active DMF
• ARCH PHARMALABS LTD1 active DMF
• Unichem Laboratories Ltd.India1 active DMF
• UNIMARK REMEDIES LTD1 active DMF
• Cipla USA, Inc.USA1 active DMF
• AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPA1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• UNIMARK REMEDIES LTD1 active DMF
• SWATI SPENTOSE PRIVATE LTD1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF

Showing 25 of 41 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (31 approved US products), the latest listed US patent on Meloxicam expires 30 Jul 2041. Generic API sourcing typically opens up once these lapse.

Therapeutic areas